U.S., Asia, Pharmanex Score for Nu Skin

U.S., Asia, Pharmanex Score for Nu Skin

PROVO, UtahNu SkinEnterprises Inc. (NYSE:NUS) reported second quarter revenues of $310.1 million,the largest-revenue quarter ever in company history, due primarily to salesgrowth in domestic and Asian markets, as well as huge increases in its Pharmanexbusiness. Nu Skin personal care revenues declined 10 percent, as companydistributors focused on Pharmanex, which climbed 29 percent to $175.6 million insales. Overall, North America and greater China posted near double digitincreases, while other Asian markets showed steady gains. Net income rose 14percent to $22.8 million or $0.32 per share compared to a year ago.